Adaptive Biotechnologies ADPT Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's accrued manufacturing costs?
- Adaptive Biotechnologies (ADPT) reported accrued manufacturing costs of $6.22M in Q1 2026.
- How has Adaptive Biotechnologies's accrued manufacturing costs changed year-over-year?
- Adaptive Biotechnologies's accrued manufacturing costs decreased by 3.0% year-over-year, from $6.41M to $6.22M.
- What is the long-term trend for Adaptive Biotechnologies's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's accrued manufacturing costs has grown at a 7.3% compound annual growth rate (CAGR), from $11.95M to $16.99M.